Indonesia · Delayed Price · Currency is IDR PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.59 trillion. The enterprise value is 1.24 trillion.
| Market Cap | 1.59T |
| Enterprise Value | 1.24T |
Important Dates
The last earnings date was Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 6.52.
| PE Ratio | 6.52 |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | 4.41 |
| P/OCF Ratio | 4.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.51, with an EV/FCF ratio of 3.44.
| EV / Earnings | 5.09 |
| EV / Sales | 1.03 |
| EV / EBITDA | 3.51 |
| EV / EBIT | 3.86 |
| EV / FCF | 3.44 |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.26 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 183.83 |
Financial Efficiency
Return on equity (ROE) is 27.36% and return on invested capital (ROIC) is 36.76%.
| Return on Equity (ROE) | 27.36% |
| Return on Assets (ROA) | 18.02% |
| Return on Invested Capital (ROIC) | 36.76% |
| Return on Capital Employed (ROCE) | 31.31% |
| Weighted Average Cost of Capital (WACC) | 3.68% |
| Revenue Per Employee | 3.25B |
| Profits Per Employee | 660.97M |
| Employee Count | 369 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 1.78 |
Taxes
In the past 12 months, PT Merck Tbk has paid 83.44 billion in taxes.
| Income Tax | 83.44B |
| Effective Tax Rate | 25.49% |
Stock Price Statistics
The stock price has increased by +10.25% in the last 52 weeks. The beta is -0.11, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | +10.25% |
| 50-Day Moving Average | 3,191.60 |
| 200-Day Moving Average | 3,058.25 |
| Relative Strength Index (RSI) | 69.77 |
| Average Volume (20 Days) | 48,510 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.20 trillion and earned 243.90 billion in profits. Earnings per share was 544.41.
| Revenue | 1.20T |
| Gross Profit | 571.30B |
| Operating Income | 321.36B |
| Pretax Income | 327.34B |
| Net Income | 243.90B |
| EBITDA | 346.96B |
| EBIT | 321.36B |
| Earnings Per Share (EPS) | 544.41 |
Balance Sheet
The company has 363.85 billion in cash and 14.23 billion in debt, with a net cash position of 349.62 billion or 780.41 per share.
| Cash & Cash Equivalents | 363.85B |
| Total Debt | 14.23B |
| Net Cash | 349.62B |
| Net Cash Per Share | 780.41 |
| Equity (Book Value) | 975.71B |
| Book Value Per Share | 2,177.93 |
| Working Capital | 801.46B |
Cash Flow
In the last 12 months, operating cash flow was 376.52 billion and capital expenditures -15.62 billion, giving a free cash flow of 360.90 billion.
| Operating Cash Flow | 376.52B |
| Capital Expenditures | -15.62B |
| Depreciation & Amortization | 25.42B |
| Net Borrowing | -8.34B |
| Free Cash Flow | 360.90B |
| FCF Per Share | 805.58 |
Margins
Gross margin is 47.58%, with operating and profit margins of 26.76% and 20.31%.
| Gross Margin | 47.58% |
| Operating Margin | 26.76% |
| Pretax Margin | 27.26% |
| Profit Margin | 20.31% |
| EBITDA Margin | 28.90% |
| EBIT Margin | 26.76% |
| FCF Margin | 30.06% |
Dividends & Yields
This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 4.79%.
| Dividend Per Share | 170.00 |
| Dividend Yield | 4.79% |
| Dividend Growth (YoY) | -46.88% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.23% |
| Buyback Yield | -0.21% |
| Shareholder Yield | 4.58% |
| Earnings Yield | 15.34% |
| FCF Yield | 22.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 6.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.46 |
| Piotroski F-Score | 5 |